Jurkat细胞
阿佩林
T淋巴细胞
白细胞介素2受体
细胞毒性T细胞
CD28
分子生物学
T细胞
CD3型
化学
淋巴细胞
生物
抗原
生物化学
免疫系统
免疫学
受体
CD8型
体外
作者
Ming Wei,Lu Gan,Jin Hou,Lihong Chen,Yantong Liu,Ligang Ren
出处
期刊:PubMed
日期:2016-12-01
卷期号:32 (12): 1641-1645
被引量:2
摘要
Objective To investigate the effect of (Pyr1)apelin-13 on the proliferation and activation of Jurkat T lymphocytes. Methods Jurkat T cells were treated by 0, 10, 50 nmol/L (Pyr1)apelin-13 for 24 hours and cell proliferation ability was detected by CCK-8 assay. The effect of (Pyr1)apelin-13 on the activation of Jurkat T lymphocytes with anti-CD3 and anti-CD28 antibodies was observed and the molecular mechanism was investigated. Quantitative real-time PCR was applied to detect the expressions of CD69, CD25, cytotoxic T lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) mRNAs. Results The proliferation of Jurkat T cells was not affected by (Pyr1) apelin-13. However, (Pyr1)apelin-13 increased the expressions of CD69 and CD25 and then activated Jurkat T lymphocytes. Furthermore, the expressions of CTLA-4 and PD-1 had no difference between activation group and (Pyr1)apelin-13 group. Conclusion (Pyr1)apelin-13 promotes Jurkat T lymphocyte activation by increasing the expressions of CD69 and CD25.
科研通智能强力驱动
Strongly Powered by AbleSci AI